BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10022222)

  • 21. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice.
    Maeda A; Maeda T; Ohguro H; Palczewski K; Sato N
    Eur J Immunol; 2002 Aug; 32(8):2300-7. PubMed ID: 12209643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer-associated retinopathy associated with invasive thymoma.
    Katsuta H; Okada M; Nakauchi T; Takahashi Y; Yamao S; Uchida S
    Am J Ophthalmol; 2002 Sep; 134(3):383-9. PubMed ID: 12208250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management and monitoring of cancer-associated retinopathy.
    Keltner JL; Thirkill CE; Tyler NK; Roth AM
    Arch Ophthalmol; 1992 Jan; 110(1):48-53. PubMed ID: 1310001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy.
    Adamus G
    Autoimmun Rev; 2003 Mar; 2(2):63-8. PubMed ID: 12848960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraperitoneal cultivation of small-cell carcinoma induces expression of the retinal cancer-associated retinopathy antigen.
    Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
    Arch Ophthalmol; 1993 Jul; 111(7):974-8. PubMed ID: 8392328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines.
    Matsubara S; Yamaji Y; Sato M; Fujita J; Takahara J
    Br J Cancer; 1996 Nov; 74(9):1419-22. PubMed ID: 8912538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive thymoma with paraneoplastic retinopathy.
    Yamada G; Ohguro H; Aketa K; Itoh T; Shijubo N; Takahashi H; Fujiwara O; Satoh M; Ohtsuka K; Abe S
    Hum Pathol; 2003 Jul; 34(7):717-9. PubMed ID: 12874770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
    Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
    Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cancer-associated retinopathy antigen is a recoverin-like protein.
    Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological roles of recoverin in cancer-associated retinopathy.
    Ohguro H; Nakazawa M
    Adv Exp Med Biol; 2002; 514():109-24. PubMed ID: 12596918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated retinopathy.
    Goldstein SM; Syed NA; Milam AH; Maguire AM; Lawton TJ; Nichols CW
    Arch Ophthalmol; 1999 Dec; 117(12):1641-5. PubMed ID: 10604671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B; Schlote T; Besch D; Djelebova T; Wilhelm H; Zrenner E
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescein angiographic findings in a case of cancer-associated retinopathy.
    Masaoka N; Emoto Y; Sasaoka A; Fukushima A; Ueno H; Ohguro H
    Retina; 1999; 19(5):462-4. PubMed ID: 10546949
    [No Abstract]   [Full Text] [Related]  

  • 36. Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy.
    Ohguro H; Maruyama I; Nakazawa M; Oohira A
    Am J Ophthalmol; 2002 Oct; 134(4):605-7. PubMed ID: 12383822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paraneoplastic retinal degeneration, cancer-associated retinopathy].
    Kuriyama M; Fujii A; Yoneda M
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):347-50. PubMed ID: 11031966
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway.
    Shiraga S; Adamus G
    J Neuroimmunol; 2002 Nov; 132(1-2):72-82. PubMed ID: 12417436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paraneoplastic cone dysfunction: an unusual visual remote effect of cancer.
    Jacobson DM; Thirkill CE
    Arch Ophthalmol; 1995 Dec; 113(12):1580-2. PubMed ID: 7487640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.